Loading
Latest filing published 07 Apr 2017 for Marina Biotech, Inc., €8,983.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Joseph W. Ramelli discloses dealings in Marina Biotech, Inc. to SEC (Form 4). The record holds 6 filings, for trades running from 1 January 2014 to 7 April 2017.
No open-market sale appears; the market trades are 4 purchases worth €56k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. In 2017 alone, the filings show 3 purchases and no sales.
Half of the purchases are above €12k and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 7 April 2017, reports an open-market purchase of €8,983 in Marina Biotech, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations